NSF has announced that it will be taking part at Making Pharmaceuticals in Coventry, UK.
Taking place from 30 April to 1 May, the company will be available for a coffee and a chat at stand 216.
You can get involved in NSF’s open discussion on what questions are key in your organisation if you want to create long-term sustainable growth and you will learn all about the company’s EDGE toolkit.
You’ll also learn more about NSF’s pharma biotech services, including world-class regulatory and compliance consulting, auditing and training on a global basis.
NSF’s speakers include:
- Pete Gough – ‘The Impact of Brexit on Pharmaceuticals’, which will take place at 14:50pm on 30 April in Room B – Pete’s presentation will focus on the current and future impact of Brexit on the supply of medicinal products in both the EU and UK
- Lynne Byers – ‘Managing Active Pharmaceutical Ingredient Supply Chains’, which will take place at 14:40pm on 1 May in Room B – Lynne will use the recent Valsartan recalls to examine how ctive pharmaceutical ingredient (API) supply chains should be managed. The presentation will use the International Conference on Harmonisation (ICH) Q9 principles to examine how companies and regulators use the standard. Lynne will also show how the regulatory framework supports regulators and marketing authorisation holders to assure API supply chains
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
Make an enquiry
Thank you for submitting the form. Your enquiry will be submitted to the company.